Algeta ASA is a startup based in Norway, most recent round Acquired, 2 tracked investors.
Algeta ASA is a company headquartered in Norway. Algeta ASA has been acquired. Brouky records 2 investors associated with the company.
Algeta ASA develops, manufactures, and markets targeted radiopharmaceutical therapies for cancer treatment, including its lead compound Alpharadin, designed for treating bone metastases.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.